Buscador de Publicaciones

Association between bullous pemphigoid and dipeptidyl peptidase-4 inhibitors and impact of their withdrawal

Autores: Martin-Enguix, D; Ruiz-Villaverde, R; Galán-Gutiérrez, M; Cabrerizo-Carvajal, AM

[Translated article] Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis

Autores: Ruiz-Villaverde, R; Galán-Gutiérrez, M; Llamas-Velasco, M; Salgado-Boquete, L; Puig, L; de la Cueva, P; Carrascosa, JM

Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real clinical practice in Andalucia, Spain

Autores: Galan-Gutierrez, M; Font-Ugalde, P; Padial, E; Hernandez-Montoya, C; Godoy, D; Armario-Hita, JC; Ruiz-Villaverde, R

Selection of Quality Indicators for the Certification of Psoriasis Units: The CUDERMA Project Delphi Consensus Study

Autores: Salgado-Boquete, L; Arias-Santiago, S; Belinchon-Romeroe, I; Cuadra-Grande, AD; Cueva, PD; Gilaberte, Y; Notario, J; Rivera-Diaz, R; Ruiz-Villaverde, R; Carrascosao, JM; Group, MGAC

Simultaneous appearance of granulomas in different tattoos: An unusual form of scar sarcoidosis

Autores: Enguix, DM; Gil-Villalba, A; Ruiz-Villaverde, R

Successful treatment of chronic actinic dermatitis with alitretinoin: Should retinoids be included in the therapeutical arsenal?

Autores: Prados-Carmona, A; Ruiz-Villaverde, R; Aranda, MVD; Arjona, JA; Navarro-Triviño, FJ

Switching from reference adalimumab to biosimilar. Assessment of clinical outcomes in psoriasis

Autores: Ruiz-Villaverde, R; Velasco-Amador, JP; Prados-Carmona, A; Ruiz-Carrascosa, JC

< 1 2 … 528 529 530 … 1.706 1.707 >